Dana Krauß (Dana Krauss)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Ejection Fraction

Childhood Cancer

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Barizah Malik, Iva Vokic, Thomas Mohr, Marle Poppelaars, Martin Holcmann, Philipp Novoszel, Gerald Timelthaler, Thomas Lendl, Dana Krauß, Ulrich Elling, Michael Mildner, Josef M Penninger, Peter Petzelbauer, Maria Sibilia, Agnes Csiszar
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice. EMBO molecular medicine (2023)
Bernadette Mödl, Monira Awad, Daniela Zwolanek, Irene Scharf, Katharina Schwertner, Danijela Milovanovic, Doris Moser, Katy Schmidt, Petra Pjevac, Bela Hausmann, Dana Krauß, Thomas Mohr, Jasmin Svinka, Lukas Kenner, Emilio Casanova, Gerald Timelthaler, Maria Sibilia, Sigurd Krieger, Robert Eferl
Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. EMBO reports (2023)
Dana Krauß, Ourania Fari, Maria Sibilia
Lipid Metabolism Interplay in CRC-An Update. Metabolites 12 (3) (2022)